These results suggest that OSA should be screened for patients with HOCM and further studies are needed to evaluate the effects of treating OSA on hs‐CRP level as well as clinical outcomes for these patients over the long term. This evidence concerns the gene MAP3K14 and obstructive sleep apnea syndrome.